Bipolar Disorder Trial, Recruiting NCT07556692 Sponsor: King's College London Condition: Bipolar Disorder
Back to Bipolar Disorder

Bipolar Disorder Trial, Recruiting

NCT07556692
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You have been diagnosed with bipolar disorder and are currently going through a depressive episode, confirmed through a structured clinical interview
  • Your depression symptoms are at least moderate in severity, based on a specific rating scale used by the research team
  • You are either not taking antidepressant medication, or you have been on a stable dose of antidepressants for at least 6 weeks before joining
  • You are either not currently in therapy, or you have been attending ongoing therapy consistently for at least 6 weeks before joining
  • You are currently under the care of a GP (family doctor)
  • You are happy for the research team to keep your GP regularly updated about your participation
  • You are able to read, understand, and sign a consent form agreeing to take part

Who may not be able to join:

  • You are considered to be at significant risk of suicide, based on answers to a standard safety questionnaire used by the research team
  • You have another major mental health condition (such as obsessive compulsive disorder) as your primary diagnosis
  • Your score on a scale measuring manic symptoms is 20 or above, suggesting significant manic symptoms
  • You currently take certain medications every day that affect brain activity (such as benzodiazepines, for example diazepam/Valium)
  • You currently use illegal drugs, or you drink heavily in a way that suggests a high risk of alcohol problems (based on a short questionnaire)
  • You have previously had any brain stimulation treatments for depression, such as electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), or deep brain stimulation, or have had brain surgery for depression
  • You have previously been treated for depression using esketamine or ketamine
  • You have a physical health condition that could be causing or mimicking mood symptoms (such as a hormonal disorder) (confirm with trial site)
  • You have a history of heart attack, heart bypass surgery, heart failure, or other significant heart problems
  • You have a condition affecting memory or thinking, such as dementia
  • You have a history of a neurological condition, such as stroke, epilepsy, seizures, or Parkinson's disease
  • You have a history of migraines or persistent, hard-to-treat headaches
  • You have any implant in your brain, a defect in your skull, or an active medical implant device in your body
  • You have shrapnel or any metal fragments in your head
  • You are female, could potentially become pregnant, and are currently pregnant or planning to become pregnant during the study
  • You are already taking part in another clinical research trial that involves a treatment or intervention

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0207848832

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
24 April 2026
Est. completion
30 April 2027

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

To determine clinical efficacy of a 10-week course of home-based tDCS for bipolar depression in terms of depressive symptoms as measured by clinician-rated MADRS score in active and sham treatment arms at week 10

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov